Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-04

Clinical Trial Update: Supplemental Hydrogen Plus PQQ for Mitochondrial Biomarkers and Brain Function in Elderly With Mild Cognitive Impairment [NA]

View source ↗

Summary

This entry notes the completed status of a clinical trial evaluating a hydrogen plus PQQ supplement for mitochondrial biomarkers and brain function in older adu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydrogen plus PQQ supplement (molecular hydrogen and pyrroloquinoline quinone (PQQ))

Snippet

Sponsor: University of Novi Sad, Faculty of Sport and Physical Education | Conditions: Age-associated Memory Impairment | NA | Status: COMPLETED